The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. Your Contributions (include, but are not limited to): Providing strategic IP counsel to business development, research, legal, senior leadership and other cross-functional stakeholders on IP-related deal structure, risk allocation, and contractual protections, including license grants, sublicensing rights, exclusivity, improvements, background and foreground IP, patent prosecution and enforcement, and rights following termination.